What are the Challenges in Targeting Tumor Blood Supply?
Despite the promise of anti-angiogenic therapies, several challenges remain. Tumors can adapt to the loss of blood supply by becoming more aggressive or by finding alternative pathways to sustain their growth. Additionally, the abnormal structure of tumor blood vessels can make it difficult for therapeutic agents to penetrate effectively. Understanding these challenges is essential for developing more effective treatments.
